Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer

References

• Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–648. doi:10.1016/S0140-6736(20)31288-5
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Katai H, Ishikawa T, Akazawa K, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer. 2018;21:144–154. doi:10.1007/s10120-017-0716-7
   PubMed Web of Science ®Google Scholar
• Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3’ UTRs and near stop codons. Cell. 2012;149:1635–1646.
   PubMed Web of Science ®Google Scholar
• Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201–206. doi:10.1038/nature11112
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885–887. doi:10.1038/nchembio.687
   PubMed Web of Science ®Google Scholar
• Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28:616–624. doi:10.1038/s41422-018-0040-8
   PubMed Web of Science ®Google Scholar
• Fazi F, Fatica A. Interplay between N6-methyladenosine (m6A) and non-coding RNAs in cell development and cancer. Front Cell Dev Biol. 2019;7:116. doi:10.3389/fcell.2019.00116
   PubMed Web of Science ®Google Scholar
• Pinello N, Sun S, Wong JJ. Aberrant expression of enzymes regulating m(6)A mRNA methylation: implication in cancer. Cancer Biol Med. 2018;15:323–334. doi:10.20892/j.issn.2095-3941.2018.0365
   PubMed Web of Science ®Google Scholar
• Selberg S, Blokhina D, Aatonen M, et al. Discovery of small molecules that activate RNA methylation through cooperative binding to the METTL3-14-WTAP complex active site. Cell Rep. 2019;26:3762–3771.e3765. doi:10.1016/j.celrep.2019.02.100
   PubMed Web of Science ®Google Scholar
• Chen J, Du B. Novel positioning from obesity to cancer: FTO, an m(6)A RNA demethylase, regulates tumour progression. J Cancer Res Clin Oncol. 2019;145:19–29. doi:10.1007/s00432-018-2796-0
   PubMed Web of Science ®Google Scholar
• Xu X, Zhou E, Zheng J, et al. Prognostic and predictive value of m6A “eraser” related gene signature in gastric cancer. Front Oncol. 2021;11:631803. doi:10.3389/fonc.2021.631803
   PubMed Web of Science ®Google Scholar
• Zhang B, Wu Q, Li B, et al. m(6)A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer. 2020;19:53. doi:10.1186/s12943-020-01170-0
   PubMed Web of Science ®Google Scholar
• Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145–166. doi:10.1146/annurev-biochem-051410-092902
   PubMed Web of Science ®Google Scholar
• Luo Y, Yang J, Yu J, et al. Long non-coding RNAs: emerging roles in the immunosuppressive tumor microenvironment. Front Oncol. 2020;10:48. doi:10.3389/fonc.2020.00048
   PubMed Web of Science ®Google Scholar
• Xu M, Xu X, Pan B, et al. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Mol Cancer. 2019;18:135. doi:10.1186/s12943-019-1063-6
   PubMed Web of Science ®Google Scholar
• Yi L, Wu G, Guo L, Zou X, Ad Huang P. Comprehensive analysis of the PD-L1 and immune infiltrates of m(6)A RNA methylation regulators in head and neck squamous cell carcinoma. Mol Ther Nucleic Acids. 2020;21:299–314. doi:10.1016/j.omtn.2020.06.001
   PubMedGoogle Scholar
• Yu J, Mao W, Sun S, et al. Identification of an m6A-related lncRNA signature for predicting the prognosis in patients with kidney renal clear cell carcinoma. Front Oncol. 2021;11:663263. doi:10.3389/fonc.2021.663263
   PubMed Web of Science ®Google Scholar
• Huang S, Lyu S, Gao Z, et al. m6A-related lncRNAs are potential biomarkers for the prognosis of metastatic skin cutaneous melanoma. Front Mol Biosci. 2021;8:687760. doi:10.3389/fmolb.2021.687760
   PubMed Web of Science ®Google Scholar
• Chen P, Yang Y, Zhang Y, Jiang S, Li X, Wan J. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer. Aging. 2020;12:3371–3387. doi:10.18632/aging.102817
   PubMedGoogle Scholar
• Li J, Li X, Zhang C, Zhang C, Wang H. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer. Oncol Rep. 2020;43:795–806. doi:10.3892/or.2020.7464
   PubMed Web of Science ®Google Scholar
• Yang S, Liu T, Nan H, et al. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma. J Cell Physiol. 2020;235:1025–1035. doi:10.1002/jcp.29018
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang S, Wang Q, Zhang X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol Oncol. 2017;10:36. doi:10.1186/s13045-017-0408-0
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Peng LS, Zhao YL, et al. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Cancer Immunol Immunother. 2012;61:1965–1975.
   PubMed Web of Science ®Google Scholar
• Kono K, Nakajima S, Mimura K. Current status of immune checkpoint inhibitors for gastric cancer. Gastric Cancer. 2020;23:565–578. doi:10.1007/s10120-020-01090-4
   PubMed Web of Science ®Google Scholar
• Esmaily M, Masjedi A, Hallaj S, et al. Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine. J Control Release. 2020;326:63–74. doi:10.1016/j.jconrel.2020.06.017
   PubMed Web of Science ®Google Scholar
• Wei L, Sun J, Zhang N, et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19:62. doi:10.1186/s12943-020-01185-7
   PubMed Web of Science ®Google Scholar
• Qiao XL, Zhong ZL, Dong Y, Gao F. LncRNA HMGA1P4 promotes cisplatin-resistance in gastric cancer. Eur Rev Med Pharmacol Sci. 2020;24:8830–8836. doi:10.26355/eurrev_202009_22822
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li M, Zhang Z. LncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p. Onco Targets Ther. 2020;13:1343–1354. doi:10.2147/OTT.S196619
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572–1573. doi:10.1093/bioinformatics/btq170
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. doi:10.1038/ncomms3612
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One. 2014;9:e107468. doi:10.1371/journal.pone.0107468
   PubMed Web of Science ®Google Scholar